Infographic: Infliximab Biosimilars in the United States

Where does the market for infliximab stand in the United States? Our infographic provides a brief history of Remicade and its biosimilars.

Related Content:

Rheumatology

Biosimilars Rheumatology Roundup: June 2025

Adalimumab Double Take: The Unexpected Return to Reference Humira

Tocilizumab Biosimilar CT-P47 Shows Promise for Rheumatoid Arthritis Self-Administration